Sissetulev kiriAvalik
Euroopa farmakopöa töökava asjus
Ravimiamet · 29. aprill 2025
- Viit
- REP-1/2188-1
- Registreeritud
- 29. aprill 2025
- Dokumendi liik
- Sissetulev kiri
- Adressaat
- European Directorate for the Quality of Medicines & HealthCare
- Saabumis/saatmisviis
- e-post
- Funktsioon
- REP Euroopa Farmakopöaga seotud asjaajamine
- Sari
- REP-1 Euroopa Farmakopöa alane kirjavahetus
- Toimik
- REP-1/2025
- Vastutaja
- Signe Leito (RA, Peadirektori asetäitja valdkond, Labor)
Sisu (failidest)
Signe Leito
Saatja: [email protected]
Saatmisaeg: esmaspäev, 28. aprill 2025 15:21
Adressaat: Signe Leito
Teema: Survey: Addition to the work programme (P1 procedure): Citicoline sodium: EDQM-2025-01794-mail
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada.
Please make sure to include in any reply our mail reference: EDQM-2025-01794-mail
****************************************************************************
For the attention of NPAs
Copy: Presidium
Dear Colleagues,
Please find below the link to a survey being carried out concerning the proposed addition of Citicoline sodium to the work programme of Group 11.
In order to have access to the survey, please copy and paste the following link into your Internet browser:
https://survey.edqm.eu/index.php?r=survey/index&sid=257437&lang=en
Deadline for replies: 28 May 2025.
Thank you.
Best regards,
On behalf of Aurelie BARTH
Andreea Mocoi
Administrative Support Assistant
European Pharmacopoeia Department
EDQM
Council of Europe
Tel.: +33 (0)3 90 21 64 63 / Fax: +33
(0)3 88 41 27 71
https://www.edqm.eu / https://www.edqm.eu/store
1
Stay connected with the EDQM
****************************************************************************
Please make sure to include in any reply our mail reference: EDQM-2025-01794-mail
2